| 0 | 💬 0 |
Single- and dual-target CAR-T cells targeting HBsAg and GPC3 to balance safety and antitumor efficacy in HBV-positive hepatocellular carcinoma.
(linkinghub.elsevier.com)
|
iScience 2026-07-21 | #car-t #hepatocellular carcinoma #immunotherapy #antigen #toxicity |